This site is for customers in Asia. Customers in China & other regions, please go to Global page.
HOME > Product search results > Code No. CY-1168 CycLex® AKT/PKB Kinase Assay/Inhibitor Screening Kit

Code No. CY-1168

CycLex® AKT/PKB Kinase Assay/Inhibitor Screening Kit

Availability (in Japan)

(Contact us)

(In Japan at 00:05,
Oct 29, 2021 in JST)


96 assays


Components Microplate, 10x Wash Buffer, Kinase Buffer, 20x ATP, HRP-conjugated Detection Antibody, Substrate Reagent, Stop Solution
Intended use This Kit is designed to measure the activities of purified AKTs for the rapid and sensitive evaluation of inhibitors or activators
Storage temp. 4°C Manufacturer MBL
Related products CY-E1168-1 AKT1 Positive Control
CY-E1168-2 AKT2 Positive Control
  1. Hideo Mure, Kazuhito Matsuzaki, Keiko T. Kitazato, Yoshifumi Mizobuchi, Kazuyuki Kuwayama, Teruyoshi Kageji, and Shinji Nagahiro; Akt2 and Akt3 play a pivotal role in malignant gliomas. Neuro Oncology, 12: 221-232, 2010(PMID:20167810)
  1. Bresin A et al. T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1. PLoS One. 13, e0204775 (2018)(PMID:30286151)
  1. Uko NE et al. Akt Pathway Inhibition of the Solenopsin Analog, 2-Dodecylsulfanyl-1,-4,-5,-6-tetrahydropyrimidine. Anticancer Res. 39, 5329-5338 (2019)(PMID:31570426)
Product category
Research area
Drug discovery
Signal transduction

  • The availability is based on the information in Japan at 00:05, Oct 29, 2021 in JST.
  • The special price is shown in red color.
  • Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
  • For storage temparature: RT: room temparature
  • Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.